Are you Dr. Orloff?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 73 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
8613 Route 29
Ste 200N
Fairfax, VA 22031Phone+1 703-208-3155Fax+1 703-280-9596
Summary
- Dr. Gregory Orloff, MD is an oncologist in Fairfax, Virginia. He is currently licensed to practice medicine in Virginia. He is affiliated with Inova Fairfax Medical Campus, Inova Fair Oaks Hospital, and UVA Health Prince William Medical Center.
Education & Training
- Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1989 - 1993
- Brigham and Women's HospitalResidency, Internal Medicine, 1986 - 1988
- Yale School of MedicineClass of 1986
Certifications & Licensure
- VA State Medical License 1995 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Top Doctors:Washington DC Area Castle Connolly, 2012
- Top Doctors:Washington-Baltimore Castle Connolly, 2012
- Top MD Consumers Checkbook
Clinical Trials
- Relating Clinical Outcomes in Multiple Myeloma to Personal Assessment of Genetic Profile Start of enrollment: 2011 Jul 01
Publications & Presentations
PubMed
- 5 citationsComprehensive molecular profiling of multiple myeloma identifies refined copy number and expression subtypes.Sheri Skerget, Daniel Penaherrera, Ajai Chari, Sundar Jagannath, David S Siegel
Nature Genetics. 2024-09-01 - 4 citationsPreferences and Priorities for Relapsed Multiple Myeloma Treatments Among Patients and Caregivers in the United States.Daniel Auclair, Carol Mansfield, Mark A Fiala, Ajai Chari, Craig E Cole
Patient Preference and Adherence. 2022-01-01 - 15 citationsPegfilgrastim appears equivalent to daily dosing of filgrastim to treat neutropenia after autologous peripheral blood stem cell transplantation in patients with non-Ho...Robert M. Rifkin, Gary Spitzer, Gregory Orloff, Romeo A. Mandanas, Dean S. McGaughey
Clinical Lymphoma, Myeloma & Leukemia. 2010-06-01